ABK Biomedical combines the clinical market with biomaterials with a focus on treating hypervascular tumors.
ABK Biomedical combines the clinical market with biomaterials. It specializes in improving treatment options for patients with hypervascular tumors. The company is dedicated to transforming an interventional radiology procedure called embolization.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Jun 22, 2016 | Series A | $9.44M | 1 | — | — | Detail |
Jan 1, 2014 | Angel | — | 1 | — | — | Detail |
Sep 15, 2012 | Seed | — | 1 | — | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
Innovacorp | — | Series A |
Wilmington Investor Network | — | Angel |